These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31136683)

  • 1. Illustration of a Method to Incorporate Preference Uncertainty in Benefit-Cost Analysis.
    Baik S; Davis AL; Morgan MG
    Risk Anal; 2019 Nov; 39(11):2359-2368. PubMed ID: 31136683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Uncertainty Matters Under Risk Neutrality.
    Glynn D; Lomas J
    Value Health; 2023 Aug; 26(8):1151-1154. PubMed ID: 37160252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliciting stated preferences for health-technology adoption criteria using paired comparisons and recommendation judgments.
    Johnson FR; Backhouse M
    Value Health; 2006; 9(5):303-11. PubMed ID: 16961548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing risk preferences in cost-effectiveness analyses.
    Zivin JG; Bridges JF
    Appl Health Econ Health Policy; 2002; 1(3):135-9. PubMed ID: 14619264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the Future.
    Mauskopf J
    Value Health; 2019 May; 22(5):570-574. PubMed ID: 31104736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust network data envelopment analysis approach to evaluate the efficiency of regional electricity power networks under uncertainty.
    Fathollah Bayati M; Sadjadi SJ
    PLoS One; 2017; 12(9):e0184103. PubMed ID: 28953900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.
    Karnon J; Czoski-Murray C; Smith K; Brand C; Chakravarthy U; Davis S; Bansback N; Beverley C; Bird A; Harding S; Chisholm I; Yang YC
    Health Technol Assess; 2008 Jun; 12(27):iii-iv, ix-124. PubMed ID: 18513468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertainty-Adjusted Translation for Preference-Sensitive Decision Support.
    Dowie J; Kaltoft MK
    Stud Health Technol Inform; 2019; 258():174-178. PubMed ID: 30942740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some Health States Are Better Than Others: Using Health State Rank Order to Improve Probabilistic Analyses.
    Goldhaber-Fiebert JD; Jalal HJ
    Med Decis Making; 2016 Nov; 36(8):927-40. PubMed ID: 26377369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
    Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
    Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An Illustration.
    Eeren HV; Schawo SJ; Scholte RH; Busschbach JJ; Hakkaart L
    PLoS One; 2015; 10(7):e0131255. PubMed ID: 26146831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Variability and Uncertainty of Electric Vehicle Life Cycle CO₂ Emissions across the United States.
    Tamayao MA; Michalek JJ; Hendrickson C; Azevedo IM
    Environ Sci Technol; 2015 Jul; 49(14):8844-55. PubMed ID: 26125323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electricity generation: options for reduction in carbon emissions.
    Whittington HW
    Philos Trans A Math Phys Eng Sci; 2002 Aug; 360(1797):1653-68. PubMed ID: 12460490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty and the Undervaluation of Services for Severe Health States in Cost-Utility Analyses.
    Richardson J; Iezzi A; Maxwell A
    Value Health; 2018 Jul; 21(7):850-857. PubMed ID: 30005758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Probabilistic Efficiency Frontier: A Framework for Cost-Effectiveness Analysis in Germany Put into Practice for Hepatitis C Treatment Options.
    Mühlbacher AC; Sadler A
    Value Health; 2017 Feb; 20(2):266-272. PubMed ID: 28237207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity-Adjusted Probability of Being Cost Effective.
    Versteegh MM; Ramos IC; Buyukkaramikli NC; Ansaripour A; Reckers-Droog VT; Brouwer WBF
    Pharmacoeconomics; 2019 Sep; 37(9):1155-1163. PubMed ID: 31134467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility measurement in healthcare: the things I never got to.
    Torrance GW
    Pharmacoeconomics; 2006; 24(11):1069-78. PubMed ID: 17067192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad ranges of investment configurations for renewable power systems, robust to cost uncertainty and near-optimality.
    Neumann F; Brown T
    iScience; 2023 May; 26(5):106702. PubMed ID: 37216107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.